BiotechTube
Home/Aptose Biosciences/Denis R. Burger, Ph.D.
DR

Denis R. Burger, Ph.D.

Board Member, Lead Director

Aptose Biosciences

Therapeutic Areas

Hematologic MalignanciesOncology

Aptose Biosciences Pipeline

DrugIndicationPhase
Tuspetinib (HM43239)Relapsed/Refractory AMLPhase 1/2
Luxeptinib (CG-806)Relapsed/Refractory B-cell malignancies (CLL, NHL)Phase 1a/b

Leadership Team at Aptose Biosciences

WG
William G. Rice, Ph.D.
Chairman of the Board, President & Chief Executive Officer
RB
Rafael Bejar, M.D., Ph.D.
Senior Vice President, Chief Medical Officer
FP
Fletcher Payne
Senior Vice President, Chief Financial Officer & Chief Business Officer
EM
Erich M. Platzer, M.D., Ph.D.
Board Member
BD
Brian Druker, M.D.
Scientific Advisory Board Member
View full Aptose Biosciences profile